Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 1,652 shares at $202.84 ($335K) on 2026-05-26, disclosed to the SEC on 2026-05-28.
Scheduled sale ($335k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |